Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli

Gaurav et al. report a synergistic interaction between nalidixic acid and tetracycline against multi-drug resistant bacteria Acinetobacter baumannii and Escherichia coli. They find that this synergy does not work for clinical isolates susceptible to antibiotics, suggesting the potential application...

Full description

Bibliographic Details
Main Authors: Amit Gaurav, Varsha Gupta, Sandeep K. Shrivastava, Ranjana Pathania
Format: Article
Language:English
Published: Nature Portfolio 2021-05-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-021-02074-5
_version_ 1818992695038705664
author Amit Gaurav
Varsha Gupta
Sandeep K. Shrivastava
Ranjana Pathania
author_facet Amit Gaurav
Varsha Gupta
Sandeep K. Shrivastava
Ranjana Pathania
author_sort Amit Gaurav
collection DOAJ
description Gaurav et al. report a synergistic interaction between nalidixic acid and tetracycline against multi-drug resistant bacteria Acinetobacter baumannii and Escherichia coli. They find that this synergy does not work for clinical isolates susceptible to antibiotics, suggesting the potential application of nalidixic acid and tetracycline against the emergence of multi-drug resistant bacteria.
first_indexed 2024-12-20T20:30:14Z
format Article
id doaj.art-5fa4ed4a3c9c4db28bbbc07074870b2a
institution Directory Open Access Journal
issn 2399-3642
language English
last_indexed 2024-12-20T20:30:14Z
publishDate 2021-05-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj.art-5fa4ed4a3c9c4db28bbbc07074870b2a2022-12-21T19:27:22ZengNature PortfolioCommunications Biology2399-36422021-05-014111210.1038/s42003-021-02074-5Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coliAmit Gaurav0Varsha Gupta1Sandeep K. Shrivastava2Ranjana Pathania3Department of Biotechnology, Indian Institute of Technology RoorkeeDepartment of Microbiology, Government Medical College and Hospital ChandigarhCentre for Innovation, Research and Development, Dr. B. Lal Clinical Laboratory Pvt LtdDepartment of Biotechnology, Indian Institute of Technology RoorkeeGaurav et al. report a synergistic interaction between nalidixic acid and tetracycline against multi-drug resistant bacteria Acinetobacter baumannii and Escherichia coli. They find that this synergy does not work for clinical isolates susceptible to antibiotics, suggesting the potential application of nalidixic acid and tetracycline against the emergence of multi-drug resistant bacteria.https://doi.org/10.1038/s42003-021-02074-5
spellingShingle Amit Gaurav
Varsha Gupta
Sandeep K. Shrivastava
Ranjana Pathania
Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
Communications Biology
title Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
title_full Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
title_fullStr Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
title_full_unstemmed Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
title_short Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
title_sort mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of acinetobacter baumannii and escherichia coli
url https://doi.org/10.1038/s42003-021-02074-5
work_keys_str_mv AT amitgaurav mechanisticinsightsintosynergybetweennalidixicacidandtetracyclineagainstclinicalisolatesofacinetobacterbaumanniiandescherichiacoli
AT varshagupta mechanisticinsightsintosynergybetweennalidixicacidandtetracyclineagainstclinicalisolatesofacinetobacterbaumanniiandescherichiacoli
AT sandeepkshrivastava mechanisticinsightsintosynergybetweennalidixicacidandtetracyclineagainstclinicalisolatesofacinetobacterbaumanniiandescherichiacoli
AT ranjanapathania mechanisticinsightsintosynergybetweennalidixicacidandtetracyclineagainstclinicalisolatesofacinetobacterbaumanniiandescherichiacoli